Home » Olympics, English hoax: anti-doping investigation into the first 4X100 relay runner. The silver medal is at risk

Olympics, English hoax: anti-doping investigation into the first 4X100 relay runner. The silver medal is at risk

by admin

The final of the 4×100 men relay at the Tokyo Olympic Games is back to talk, ending with the gold of the blue quartet composed of Lorenzo Patta, Fausto Desalu, Filippo Tortu and the 100-meter Olympic champion Marcell Jacobs. The first relay runner of Great Britain, Chijindu Ujah, is under investigation for a possible violation of the anti-doping rules, a violation that if confirmed could lead to a suspension and cancellation of the silver for the British team beaten for a single cent by the Azzurri. Athletics Integrity Unity revealed in the doping test carried out by Ujah at the end of the relay an abnormal amount of ostarine, an anabolic agent, present in the list of prohibited substances of the World Anti-Doping Agency. The same British Anti-Doping website reports that it has ‘testosterone-like effects’.

Athletics, Jacobs announces the stop: “I’ll be back in the race in 2022”

Ujah, 27 and winner of the 100m at the British Championships in June, was provisionally suspended creating a huge embarrassment for the Great Britain team who had never had a higher profile doping case at any Olympics. A UK Athletics spokesperson said the governing body does not comment on the ongoing trials. And now we will see what the English newspapers, suspicious of Jacobs, will write after this story. Two substances that Ujah would have taken: S23, which aids in muscle building, and Ostarine, an anabolic.

Three other athletes were suspended after tests carried out during the Tokyo Olympics: 1500m runner from Bahrain Sadik Mikhou, shot put athlete Benik Abramyan of Georgia and Kenyan sprinter Mark Otieno Odhiambo.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy